We speculate that CSS may regulate the activity of immune‐related factors in the tumour microenvironment, reverse immune escape, enhance immune responses through AKT1, MAPK3, and CASP3, and synergistically alleviate HCC. This evidence concerns the gene AKT1 and hepatocellular carcinoma.